A Multicenter Phase II Trial of Vinorelbine Plus Gemcitabine in Previously Untreated Inoperable (Stage IIIB/IV) Non-small Cell Lung Cancer
- 1 June 2000
- Vol. 117 (6) , 1583-1589
- https://doi.org/10.1378/chest.117.6.1583
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Phase II Trial of Vinorelbine and Cisplatin in Previously Untreated Inoperable Non—Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 2000
- Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatinCancer, 1999
- Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology GroupJournal of Clinical Oncology, 1999
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb–IV non-small cell lung cancer (NSCLC)Lung Cancer, 1999
- Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1998
- A review of the pharmacology and clinical activity of new chemotherapeutic agents in lung cancerCancer Treatment Reviews, 1998
- Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinomaCancer, 1998
- Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.Journal of Clinical Oncology, 1997
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989